- Organizes content both by individual pathogens and by important clinical syndromes, broadening the context to clearly present relevant, complex clinical information.
- Contains multiple new chapters on both SARS-CoV-2 and anti-fungal therapy, as well as new chapters on bacteriophages and related agents, infections following traumatic injuries, and communication to the public about infectious diseases
- Provides up-to-date coverage of recent advances in the field: an increasing understanding of the agents, immune responses, and the growing armamentarium of diagnostics (such as polymerase chain reaction and next-generation sequencing); new treatments (such as monoclonal antibodies, new antifungals, antivirals, and phage therapy); and emerging preventive measures (such as new vaccines being developed for RSV)
- Features more than 1,500 high-quality, full-color photographs?with many new to this edition
- Shares the extensive experience of new editors Drs. Jeffrey I. Cohen and Steven M. Holland, both from the National Institutes of Health, as well as a new team of expert associate editors, Drs. Yohei Doi, Wendy S. Garrett, Ann R. Falsey, Eleanor Wilson, Kieren Marr, and Edward Mitre
- Includes perspectives from hundreds of leading experts from a truly global community, including authors from Australia, Canada, and countries in Europe, Asia, and South America
- Includes regular updates online for the life of the edition
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
- Updated throughout, eg: COVID-19 content, updates on Multisystem Inflammatory Syndrome in Children (MIS-C), XDR and complicated MDR tuberculosis, HIV prevention, transplant infections, measles elimination setbacks, the use of monoclonal antibodies to target antibiotic-resistant bacterial pathogens
- Add more visuals: algorithms, text � table, short view summaries at start of chapters (not all chapters had these)
Table of Contents
PART I: BASIC PRINCIPLES IN THE DIAGNOSIS AND MANAGEMENT OF INFECTIOUS DISEASES
Section A: Microbial Pathogens
Section B: Host Defense Mechanisms
Section C: Epidemiology of Infectious Disease
Section D: Clinical Microbiology
Section E: Antiinfective Therapy
PART II: MAJOR CLINICAL SYNDROMES
Section A: Fever
Section B: Upper Respiratory Tract Infections
Section C: Pleuropulmonary and Bronchial Infections
Section D: Urinary Tract Infections
Section E: Sepsis
Section F: Intraabdominal Infections
Section G: Cardiovascular Infections
Section H: Central Nervous System Infections
Section I: Skin and Soft Tissue Infections
Section J: Gastrointestinal Infections and Food Poisoning
Section K: Bone and Joint Infections
Section L: Diseases of The Reproductive Organs and Sexually Transmitted Diseases
Section M: Eye Infections
Section N: Hepatitis
Section O: Acquired Immunodeficiency Syndrome
Section P: COVID-19
Section Q: Miscellaneous Syndromes
PART III: INFECTIOUS DISEASES AND THEIR ETIOLOGIC AGENTS
Section A: Viral Diseases
Section B: Prion Diseases
Section C: Chlamydial Diseases
Section D: Mycoplasma Diseases
Section E: Rickettsioses, Ehrlichioses, and Anaplasmoses
Section F: Bacterial Diseases
Sub-Section I. Infections due to Gram-Positive Bacteria
Sub-Section II. Infections due to Gram-Negative Bacteria
Sub-Section III. Infections due to Spirochetal Bacteria
Sub-Section IV. Infections due to Anaerobic Bacteria
Sub-Section V. Infections due to Acid-Fast Organisms
Section G: Mycoses
Section H: Protozoal Diseases
Section I: Diseases Due to Toxic Algae
Section J: Diseases Due to Helminths
Section K: Ectoparasitic Diseases
Section L: Diseases of Unknown Etiology
PART IV: SPECIAL PROBLEMS
Section A: Nosocomial Infections
Section B: Infections in Special Hosts
Section C: Surgical- and Trauma-Related Infections
Section D: Immunization
Section E: Protection of Travelers
Section F: Emerging Issues in Infectious Diseases
